ANG Lifesciences India Ltd Financials
Company Logo

ANG Lifesciences India Ltd Financial Statement

ANG Lifesciences India Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue32.52
Operating Expense29.70
Net Profit-1.07
Net Profit Margin-3.29
Earning Per Share-0.75
EBIDTA2.42
Effective Tax RateTBA
Invest in ANG Lifesciences India Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

ANG Lifesciences India Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual131.37
Operating Expenses Annual122.25
Operating Profit Annual8.22
Interest Annual9.33
Depreciation7.75
Net Profit Annual-8.65
Tax Annual-0.22

ANG Lifesciences India Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.20
Cash Flow from Operations-13.13
Cash Flow from Investing20.02
Cash Flow from Financing-7
Cash Flow at the End0.09

ANG Lifesciences India Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)7.78
PBIT Margin (%)1.88
PBT Margin (%)1.69
Net PROFIT Margin (%)-6.58
Return On Networth / Equity (%)-8.72
Return On Networth /Employed (%)1.71
Return On Assets (%)-5.99
Total Debt / Equity (X)0.71
Asset Turnover Ratio (%)0.91

ANG Lifesciences India Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual53.35
Total Current Assets Annual158.37
Non Current Assets Annual57.35
Total Shareholders Funds Annual77.07
Total Assets Annual217.43

ANG Lifesciences India Ltd Earning Calls

EPS (INR)

Expected

0.00

Reported

-1.53

Surprise

0.00%

Jun 2024

EPS beaten by 0.00%

Mar 2024

EPS beaten by 0.00%

Dec 2023

EPS beaten by 0.00%

Get Your FAQs Right

As of Nov 24, 2024, ANG Lifesciences India Ltd has a market capitalization of 58.87 Cr. Value Research classifies it as a Micro-Cap company.
No, ANG Lifesciences India Ltd is not debt-free with a debt-to-equity ratio of 0.77.
In FY 2023 , ANG Lifesciences India Ltd recorded a total revenue of approximately 131.37 Cr marking a significant milestone in the company's financial performance.
ANG Lifesciences India Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.7% and -0.5% annually, respectively..
ANG Lifesciences India Ltd's current PE ratio is -6.81.
ANG Lifesciences India Ltd's ROCE averaged 15.9% from the FY ending March 2022 to 2024, with a median of 8.4%. It peaked at 37.7% in March 2022, reflecting strong capital efficiency over the period..
ANG Lifesciences India Ltd's latest EBIT is Rs. 0.46 Cr, surpassing the average EBIT of Rs. 24.59 Cr over the 5 years..